You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
Development of P2X3 Ion Channel MAbs for the Treatment of Pain
SBC: INTEGRAL MOLECULAR INC Topic: 100DESCRIPTION provided by applicant Acute and chronic pain resulting from injury surgery or disease afflicts andgt million Americans each year having a severe impact on mood mental health and quality of life and costing the U S approximately $ billion in economic costs annually For many patients treatment options provide inadequate relief because of the shortcomings of available th ...
SBIR Phase II 2014 Department of Health and Human ServicesNational Institutes of Health -
An Early-Phase Clinical Trial Evaluating ABC294640 in Patients with Refractory/Re
SBC: Apogee Biotechnology Corporation Topic: 102DESCRIPTION provided by applicant Diffuse large B cell lymphoma DLBCL represents one of the most common variants of Non Hodgkinandapos s lymphoma NHL and oncogenic herpesviruses EBV and KSHV are the etiologic agents for the majority of these tumors in patients over or those infected with the human immunodeficiency virus HIV Despite modest improvements in outcomes for patients rece ...
STTR Phase II 2014 Department of Health and Human ServicesNational Institutes of Health -
KL4 Surfactant to Mitigate Radiation-Induced Lung Injury
SBC: DISCOVERY LABORATORIES, INC. Topic: NIAIDDESCRIPTION provided by applicant Exposure to ionizing radiation from a nuclear reactor accident or deliberate terrorist actions including the detonation of andquot dirty bombsandquot is a significant public health concern The lung is particularly susceptible to ionizing radiation injury from external sources or inhalation of radioactive particles from radioactive fall out Radiation pneumono ...
SBIR Phase II 2014 Department of Health and Human ServicesNational Institutes of Health -
Developing a Point-of-Care Device for the Diagnosis of Sickle Cell Disease in Low Resource Settings
SBC: ROCKLAND IMMUNOCHEMICALS, INC. Topic: NHLBIDESCRIPTION provided by applicant Hemoglobinopathies are the most common monogenic diseases with approximately of the worldandapos s population being carriers Sickle cell disease SCD and thalassemia are primarily hemoglobin disorders The current SCD diagnostic methods require expensive equipment and are performed by highly trained laboratory technologists Presently there are no simple ...
SBIR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health -
Preclinical testing of the splice modulating oligonucleotide LSP-GR1
SBC: LifeSplice Pharma Topic: 106DESCRIPTION provided by applicant AMPA glutamate receptors mediate the majority of fast excitatory neurotransmission in the central nervous system Four AMPA receptor subunits exist GluA GluA with functional channels containing various combinations of these four subunits Dysregulation of AMPA receptor expression has been reported in many neurological disorders including amyotrophic latera ...
SBIR Phase II 2014 Department of Health and Human ServicesNational Institutes of Health -
Engineering of membrane protein chemosensors for therapeutic research
SBC: INTEGRAL MOLECULAR INC Topic: NIDCDDESCRIPTION provided by applicant Cells require the ability to detect and respond to stimuli in their surroundings including to endogenous metabolites exogenous nutrients and environmental irritants The proteins that are responsible for this process are called chemosensors and are involved in regulating diverse biological processes involved in pain sensation dietary preference and metabol ...
SBIR Phase II 2014 Department of Health and Human ServicesNational Institutes of Health -
Ocular Formulation Development of Innovative Novel Compounds with superior ocular
SBC: CATALYST, LLC Topic: NDESCRIPTION provided by applicant As anyone who has had an eye injury or even a small foreign object in the eye knows the cornea and surrounding structures are exquisitely sensitive to physical trauma Ocular pain can be agonizing paralyzing and extremely distressing to both the affected person and particularly in the case of pediatric cases family members who may feel powerless to help S ...
SBIR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health -
Active Fine Gauge Spinal Needle with CSF Sensing to Minimize PDPH and Dura Damage
SBC: ACTUATED MEDICAL, INC. Topic: 300DESCRIPTION provided by applicant In this NIH SBIR Phase II Actuated Medical Inc will finalize and clinically test the andquot Active Fine Gauge Spinal Needle with CSF Sensing to Minimize PDPH and Dura Damage andquot Phase I achieved all Specific Aims and demonstrated that the Smooth Insertion Spinal SIS System provided greater control for the clinician by reducing the buckling of G tra ...
SBIR Phase II 2014 Department of Health and Human ServicesNational Institutes of Health -
Development of High-expressing Ion Channels for Research and Therapeutic Applicat
SBC: INTEGRAL MOLECULAR INC Topic: 300DESCRIPTION provided by applicant Ion channels such as Kv and Nav are involved in a number of human disorders including autoimmunity and pain that affect andgt million Americans annually and are poorly treated However ion channels are typically exceptionally difficult to express at high levels due to their structural complexity and toxicity s a result many research and therapeu ...
SBIR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health -
BioPrism- An Optical Chromatograph
SBC: OPTOFLUIDICS, INC. Topic: NIEHSDESCRIPTION provided by applicant Optofluidics Inc proposes to develop a near field optical chromatograph the BioPrism and apply it to the characterization of particle coating stability in nanomedicine According to clinicaltrials gov about of all clinical trials involv nanoparticles and the National Science Foundation has predicted that nearly half of future pharmaceuticals will have s ...
SBIR Phase II 2014 Department of Health and Human ServicesNational Institutes of Health